NALMEFENE HCL
LIVE

Serial Number

99710822

Owner

Purdue Pharma L.P.

Attorney

Fara S. Sunderji

Filing Date

Mar 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NALMEFENE HCL Trademark

Serial Number: 99710822

NALMEFENE HCL is a trademark filed by Purdue Pharma L.P. on March 18, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Purdue Pharma L.P.

One Stamford Forum
Stamford, CT 06901

Entity Type: 13

KNOA PHARMA LLC

ONE STAMFORD FORUM
STAMFORD, CT 06901-3431

Entity Type: 16

Trademark Details

Filing Date

March 18, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 19, 2026 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2026 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2026 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 30, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 18, 2026 MAFR
NEW APPLICATION ENTERED
Mar 18, 2026 NWAP